J&J suspends sales forecast for COVID vaccine, cuts profit view
April 19, 2022 at 12:43 PM EDT
Johnson & Johnson on Tuesday said it could no longer provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low-income countries paired with already low demand in higher-income nations has led to a glut of supply.
